Analysis – Page 364 – Goldea Capital

Biogen Completes Acquisition of Apellis Pharmaceuticals

Written by Customer Service on May 14, 2026. Posted in Mergers And Acquisitions.

CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, complement-driven diseases, is now a wholly owned subsidiary of Biogen. The acquisition adds two best-in-class commercialized products, EMPAVELI® and SYFOVRE®, significantly bolstering Biogen’s near-term growth outlook and accelerating the Company’s expansion into nephrology. Together, the products recorded $689 million in net product revenue in 2025. This transaction will strengthen Biogen’s revenue and EPS growth potential by being accretive to Biogen’s Non-GAAP diluted EPS in 2027 and is expected to materially increase Biogen’s non-GAAP EPS compound annual growth rate (CAGR) through the...

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026

Written by Customer Service on May 14, 2026. Posted in Public Companies.

GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) — 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that management will attend the upcoming Sidoti Micro-Cap Virtual Conference. 20/20 BioLabs’ Chief Executive Officer, Jonathan Cohen, will participate in one-on-one investor meetings and host a presentation from 3:15 PM ET to 3:45 PM ET in Track 1. Mr. Cohen will discuss the Company’s recently reported quarterly results, recent partnership and licensing activity, and the plans to scale the OneTest platform. Sidoti Virtual Micro-Cap Virtual Conference Date: Wednesday, May 20, 2026Format: Presentation & Virtual 1×1 MeetingsPresentation: 3:15 – 3:45 PM ET in Track...

Helport AI Launches New ‘AI Labor’ Corporate Website

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Powered by the HyprX Expert Replication Engine to Deliver Real-Time AI-Powered Expert Interaction SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), a global technology company providing enterprise clients with intelligent customer communication software and services powered by artificial intelligence (“AI”), today officially announced the launch of its next-generation AI-powered corporate website (https://www.helport.ai/), marking the commercial rollout of the company’s flagship HyprX Expert Replication Engine and reinforcing the Company’s strategic positioning as a leader in the emerging “AI Labor System” category. Unlike traditional enterprise websites built around static pages, search bars, and delayed customer response workflows, Helport AI’s new engine seeks to transform...

Phunware Appoints Dmitry Kroshka as Chief Executive Officer to Lead 2.0 Strategy; Engages Michael Cerdá to Drive Product Rollout

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Leadership Changes Align Strategy, Product Execution, and Commercial Rollout of Phunware’s Next-Generation Guest Intelligence Platform Company to Accelerate Product 2.0 Strategy Across Hospitality, Healthcare, and Large-Property Environments AI Concierge Momentum, 95%+ Customer Retention, and Strong Cash Position Provide Foundation for Next Phase of Growth AUSTIN, Texas, May 14, 2026 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a mobile-first enterprise cloud platform delivering location-aware customer intelligence and AI-enabled audience engagement tools, today announced a leadership transition and product strategy update designed to accelerate the Company’s 2.0 Strategy and expand its footprint across hospitality, healthcare, and other large-property verticals. Effective immediately, Dmitry...

Lakeland Fire + Safety’s LHD Group Australia Secures Multi-Year Extension Agreement with Energy Queensland for Field Workwear

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Extends Partnership with One of Australia’s Largest Utility Providers and Establishes Pathway to Multi-Million-Dollar Annual Revenue Contribution to Industrial Segment HUNTSVILLE, Ala., May 14, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its LHD Group Australia subsidiary has secured a multi-year extension of its field workwear agreement with Energy Queensland, one of Australia’s largest utility providers. Terms of the agreement were not disclosed. The extension reinforces Lakeland’s position as a long-term supplier to a critical infrastructure customer. Importantly, the updated agreement introduces a framework that creates meaningful...

Cycurion Reports First Quarter 2026 Results

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

Delivers 900 Basis Point Gross Margin Expansion, Net Loss Cut 51% and $21 to $22 Million Annual Revenue Visibility Turnaround Momentum MCLEAN, Va., May 14, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leader in AI-driven cybersecurity and national security solutions with trusted relationships across the U.S. Government, numerous leading corporations, and high-profile individuals across all industries, announced today results for the first quarter ended March 31, 2026. “The first quarter of 2026 marks a clear inflection point in our transformation,” said Kevin Kelly, Chairman and Chief Executive Officer of Cycurion. “We nearly doubled gross margins, significantly reduced operating expenses and executed binding agreements to acquire Halo Privacy and...

Dogwood Therapeutics Announces First Quarter 2026 Financial Results

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

– Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 – – FDA acceptance of SP16 Investigational New Drug Application for the treatment of Chemotherapy Induced Pain and Neuropathy – – Announces Worldwide Development and Commercialization Partnership for Legacy Antiviral Assets with potential value up to $100M to Dogwood and its current and former shareholders – ALPHARETTA, Ga., May 14, 2026 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid medicines to treat pain and neuropathy, today announced financial results for the first quarter ended March 31, 2026. “Dogwood is off to a strong operational start to 2026 driven by significant pipeline progress...

Live Ventures Reports Fiscal Second Quarter 2026 Financial Results

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

LAS VEGAS, May 14, 2026 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced financial results for its fiscal second quarter ended March 31, 2026. Fiscal Second Quarter 2026 Key Highlights:Revenue was $102.9 million, compared to $107.0 million in the prior-year period Gross margin increased 80 basis points to 33.6%, compared to 32.8% in the prior-year period Operating loss was $2.0 million, compared to operating income of $2.1 million in the prior-year period.Excluding a non-cash goodwill impairment charge of approximately $4.0 million in the Steel Manufacturing segment, the fiscal second quarter 2026 operating income would have been approximately $2.0 millionNet loss was $2.4 million and diluted loss per share was $0.80, compared...

Billion-Dollar AI deal, $100m in Acquisitions, $25m Founder Buy-In – Diginex Details Expansion Push

Written by Customer Service on May 14, 2026. Posted in Mergers And Acquisitions.

The Company has no debt, has completed more than US$100 million in M&A, signed a US$40 million strategic reseller agreement and had US$25.4 million in cash investment injected at share price levels ~4.7x higher than current since January 2025 Nasdaq IPO LONDON, May 14, 2026 (GLOBE NEWSWIRE) — Diginex Limited (Nasdaq: DGNX) (“Diginex” or the “Company”), a leading provider of Sustainability RegTech solutions, today provided an update on its previously announced acquisition of Resulticks Global Companies Pte Limited (Resulticks) along with the broader corporate transformation Diginex has executed since its Nasdaq listing in January 2025. Diginex and Resulticks have mutually agreed to extend the Long Stop date for Closing of the proposed transaction to May 29, 2026, as both parties work on the remaining closing condition workstreams....

Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

—New Clinical and Translational Data Presented at Major Medical Meetings Further Confirms the Disease-Modifying Potential of Nebokitug in Primary Sclerosing Cholangitis and Suggests Possible Additional Benefit in PSC Patients with Co-Existing IBD— —Company Continues to Advance Multiple Partnering Options for Nebokitug— TEL AVIV, Israel, May 14, 2026 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the first quarter ended March 31, 2026, and provided a corporate update. “In the first quarter we continued to have productive discussions with potential strategic partners while releasing new data analyses that further extend our understanding...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals